Company Dossiers

Immatics N.V. (NASDAQ: IMTX) is a clinical-stage biopharmaceutical company incorporated in the Netherlands, with its main operational assets and activities conducted through its German subsidiary, Immatics Biotechnologies GmbH, based in Tübingen. The company …

Immersion Corporation (NASDAQ: IMMR) is a leading developer and licensor of haptic feedback technology, also known as touch feedback technology. Founded in 1993 and headquartered in Aventura, Florida, the company designs, develops, and licenses patented hapti…

Immix Biopharma, Inc. (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company pioneering tissue-specific therapeutics and chimeric antigen receptor cell therapies (CAR-T). The company's primary value driver is NXC-201, a next-generation, sterically-optim…

ImmuCell Corporation (NASDAQ: ICCC) is a specialized animal health biologics company that develops, manufactures, and markets products designed to improve the health and productivity of dairy and beef cattle. The company's flagship product line, First Defense…

Immuneering Corp (Nasdaq: IMRX) is a late-stage clinical oncology company specializing in the development of a new category of cancer medicines called Deep Cyclic Inhibitors (DCIs). The company leverages its proprietary Disease Cancelling Technology (DCT) pla…

Immunic, Inc. (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases. Headquartered in New York City and founded in 2016, the company focuses on selective oral drugs in immunology. Its l…

ImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectiou…

Immunocore Holdings plc (Nasdaq: IMCR) is a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies called ImmTAX (Immune mobilizing monoclonal TCRs Against X disease). The company…

Immunome Inc. (NASDAQ: IMNM) is a clinical-stage biopharmaceutical company dedicated to developing first-in-class and best-in-class targeted cancer therapies, with a primary focus on antibody-drug conjugates (ADCs) and other innovative oncology modalities. Th…

Immunovant, Inc. is a clinical-stage immunology company dedicated to developing innovative, targeted therapies for people with autoimmune diseases. The company is a trailblazer in anti-FcRn (neonatal fragment crystallizable receptor) technology, focusing its …

Immuron Ltd (ASX: IMC; NASDAQ: IMRN) is a commercial and clinical-stage Australian biopharmaceutical company focused on the development and commercialization of orally delivered targeted polyclonal antibodies. The company's proprietary technology platform gen…

Immutep Ltd (ASX: IMM, NASDAQ: IMMP) is a late clinical-stage biotechnology company pioneering the development of novel immunotherapies for cancer and autoimmune diseases. The company is a global leader in Lymphocyte Activation Gene-3 (LAG-3) related therapeu…

Impact BioMedical Inc. (NYSE American: IBO) is a specialized biotechnology holding company focused on the discovery, development, and licensing of innovative healthcare solutions. Operating primarily as an intellectual property (IP) incubator and licensing en…

Imperial Oil Limited is one of Canada's largest integrated oil companies, active in all phases of the petroleum industry. Founded in 1880, the company is majority-owned by Exxon Mobil Corporation (holding approximately 69.6% of its common shares). Imperial op…

Imperial Petroleum Inc. (NASDAQ: IMPP) is an international seaborne transportation services provider incorporated in the Republic of the Marshall Islands and headquartered in Athens, Greece. Spun off from StealthGas Inc. in December 2021, the company operates…

Impinj, Inc. (NASDAQ: PI) is a leading provider and pioneer of RAIN RFID (Radio-Frequency Identification) technology, serving as a critical enabler of the Internet of Things (IoT). The company designs and sells a vertically integrated platform consisting of e…

Imunon, Inc. (formerly Celsion Corporation) is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array …

InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and manufacturing of proprietary small molecule drug candidates targeting the CB1 and CB2 receptors. The company operates through two primary segmen…

Incannex Healthcare Inc. (Nasdaq: IXHL) is a clinical-stage biopharmaceutical company specializing in the development of innovative combination therapies and therapeutic regimens. The company's proprietary pipeline leverages smart drug combinations pairing sy…

Income Opportunity Realty Investors, Inc. (NYSE American: IOR) is a Dallas-based, externally managed real estate investment company. The company primarily holds a portfolio of notes receivable collateralized by investments in land and/or multifamily propertie…